Skip to main content
. 2024 May;86(2):169–180. doi: 10.18999/nagjms.86.2.169

Fig. 1.

Fig. 1

Transition of standard treatment for metastatic castration-sensitive prostate cancer

ADT: androgen deprivation therapy

SOC: standard of care